# Agape ATP Corp: financial statements, quarterly

ATPC · Nasdaq · CIK 1713210 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/atpc.md) · [Financials](/companies/atpc/financials.md) · [Filings](/companies/atpc/filings.md) · [Insiders](/companies/atpc/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/atpc/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | [355](/filings/0001493152-24-045337.md) | [391 d](/filings/0001641172-25-001611.md) | [319](/filings/0001641172-25-010660.md) | [313](/filings/0001641172-25-023358.md) | [331](/filings/0001493152-25-022092.md) | [360 d](/filings/0001493152-26-016297.md) | [289](/filings/0001493152-26-023388.md) | [207](/filings/0001493152-26-037992.md) | [371](/filings/0001493152-25-022092.md) | [399 d](/filings/0001493152-26-016297.md) | [274](/filings/0001493152-26-023388.md) | [13.7](/filings/0001493152-26-037992.md) |
| Cost of revenue | $k | [121](/filings/0001493152-24-045337.md) | [138 d](/filings/0001641172-25-001611.md) | [115](/filings/0001641172-25-010660.md) | [119](/filings/0001641172-25-023358.md) | [147](/filings/0001493152-25-022092.md) | [182 d](/filings/0001493152-26-016297.md) | [133](/filings/0001493152-26-023388.md) | [142](/filings/0001493152-26-037992.md) | [131](/filings/0001493152-25-022092.md) | [165 d](/filings/0001493152-26-016297.md) | [114](/filings/0001493152-26-023388.md) | [1.9](/filings/0001493152-26-037992.md) |
| Gross profit | $k | [235](/filings/0001493152-24-045337.md) | [253 d](/filings/0001641172-25-001611.md) | [203](/filings/0001641172-25-010660.md) | [194](/filings/0001641172-25-023358.md) | [184](/filings/0001493152-25-022092.md) | [178 d](/filings/0001493152-26-016297.md) | [156](/filings/0001493152-26-023388.md) | [65.4](/filings/0001493152-26-037992.md) | [239](/filings/0001493152-25-022092.md) | [234 d](/filings/0001493152-26-016297.md) | [159](/filings/0001493152-26-023388.md) | [11.8](/filings/0001493152-26-037992.md) |
| Selling, general and administrative | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $k | [(317)](/filings/0001493152-24-045337.md) | [(1,016) d](/filings/0001641172-25-001611.md) | [(724)](/filings/0001641172-25-010660.md) | [(454)](/filings/0001641172-25-023358.md) | [(548)](/filings/0001493152-25-022092.md) | [(848) d](/filings/0001493152-26-016297.md) | [(720)](/filings/0001493152-26-023388.md) | [(622)](/filings/0001493152-26-037992.md) | [(601)](/filings/0001493152-25-022092.md) | [(1,298) d](/filings/0001493152-26-016297.md) | [(677)](/filings/0001493152-26-023388.md) | [(551)](/filings/0001493152-26-037992.md) |
| Income tax | $k | [3.9](/filings/0001493152-24-045337.md) | [6.3 d](/filings/0001641172-25-001611.md) | [6.8](/filings/0001641172-25-010660.md) | [9.8](/filings/0001641172-25-023358.md) | [(2.9)](/filings/0001493152-25-022092.md) | [(8.9) d](/filings/0001493152-26-016297.md) | not reported | not reported | [1.2](/filings/0001493152-25-022092.md) | [1.1 d](/filings/0001493152-26-016297.md) | not reported | not reported |
| Net income | $k | [(327)](/filings/0001493152-24-045337.md) | [(974) d](/filings/0001641172-25-001611.md) | [(710)](/filings/0001641172-25-010660.md) | [(443)](/filings/0001641172-25-023358.md) | [(510)](/filings/0001493152-25-022092.md) | [(808) d](/filings/0001493152-26-016297.md) | [(713)](/filings/0001493152-26-023388.md) | [(623)](/filings/0001493152-26-037992.md) | [(587)](/filings/0001493152-25-022092.md) | [(377) d](/filings/0001493152-26-016297.md) | [(341)](/filings/0001493152-26-023388.md) | [149](/filings/0001493152-26-037992.md) |
| Diluted EPS | $ per share | [(0.09)](/filings/0001493152-24-045337.md) | not reported | [(0.18)](/filings/0001641172-25-010660.md) | [(0.12)](/filings/0001641172-25-023358.md) | [(0.13)](/filings/0001493152-25-022092.md) | not reported | [(3.63)](/filings/0001493152-26-023388.md) | [(0.62)](/filings/0001493152-26-037992.md) | [(0.01)](/filings/0001493152-25-022092.md) | not reported | [(0.33)](/filings/0001493152-26-023388.md) | [0.15](/filings/0001493152-26-037992.md) |
| Basic EPS | $ per share | [(0.09)](/filings/0001493152-24-045337.md) | not reported | [(0.18)](/filings/0001641172-25-010660.md) | [(0.12)](/filings/0001641172-25-023358.md) | [(0.13)](/filings/0001493152-25-022092.md) | not reported | [(3.63)](/filings/0001493152-26-023388.md) | [(0.62)](/filings/0001493152-26-037992.md) | [(0.01)](/filings/0001493152-25-022092.md) | not reported | [(0.33)](/filings/0001493152-26-023388.md) | [0.15](/filings/0001493152-26-037992.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: not reported
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [0.3](/filings/0001493152-23-040842.md) | [4.8](/filings/0001641172-25-001611.md) | [3.6](/filings/0001493152-24-019120.md) | [3.2](/filings/0001493152-24-031883.md) | [2.7](/filings/0001493152-24-045337.md) | [2.0](/filings/0001493152-26-016297.md) | [0.6](/filings/0001641172-25-010660.md) | [0.2](/filings/0001641172-25-023358.md) | [0.1](/filings/0001493152-25-022092.md) | [0.1](/filings/0001493152-26-037992.md) | [0.2](/filings/0001493152-26-023388.md) | [0.0](/filings/0001493152-26-037992.md) |
| Current assets | $m | [0.5](/filings/0001493152-23-040842.md) | [5.2](/filings/0001641172-25-001611.md) | [4.3](/filings/0001493152-24-019120.md) | [3.8](/filings/0001493152-24-031883.md) | [3.4](/filings/0001493152-24-045337.md) | [2.8](/filings/0001493152-26-016297.md) | [24.8](/filings/0001641172-25-010660.md) | [24.3](/filings/0001641172-25-023358.md) | [24.1](/filings/0001493152-25-022092.md) | [24.3](/filings/0001493152-26-037992.md) | [24.7](/filings/0001493152-26-023388.md) | [24.8](/filings/0001493152-26-037992.md) |
| Total assets | $m | [1.7](/filings/0001493152-23-040842.md) | [5.7](/filings/0001641172-25-001611.md) | [4.8](/filings/0001641172-25-010660.md) | [4.3](/filings/0001641172-25-023358.md) | [4.0](/filings/0001493152-25-022092.md) | [3.2](/filings/0001493152-26-016297.md) | [25.2](/filings/0001493152-26-023388.md) | [24.6](/filings/0001493152-26-037992.md) | [24.4](/filings/0001493152-25-022092.md) | [24.6](/filings/0001493152-26-037992.md) | [24.9](/filings/0001493152-26-023388.md) | [25.0](/filings/0001493152-26-037992.md) |
| Current liabilities | $m | [1.0](/filings/0001493152-23-040842.md) | [1.1](/filings/0001641172-25-001611.md) | [0.8](/filings/0001493152-24-019120.md) | [0.8](/filings/0001493152-24-031883.md) | [0.9](/filings/0001493152-24-045337.md) | [1.1](/filings/0001493152-26-016297.md) | [1.0](/filings/0001641172-25-010660.md) | [1.2](/filings/0001641172-25-023358.md) | [1.5](/filings/0001493152-25-022092.md) | [2.1](/filings/0001493152-26-037992.md) | [2.7](/filings/0001493152-26-023388.md) | [2.9](/filings/0001493152-26-037992.md) |
| Total liabilities | $m | [1.2](/filings/0001493152-23-040842.md) | [1.4](/filings/0001641172-25-001611.md) | [1.1](/filings/0001493152-24-019120.md) | [1.0](/filings/0001493152-24-031883.md) | [1.2](/filings/0001493152-24-045337.md) | [1.3](/filings/0001493152-26-016297.md) | [1.2](/filings/0001641172-25-010660.md) | [1.3](/filings/0001641172-25-023358.md) | [1.6](/filings/0001493152-25-022092.md) | [2.2](/filings/0001493152-26-037992.md) | [2.8](/filings/0001493152-26-023388.md) | [3.0](/filings/0001493152-26-037992.md) |
| Shareholders' equity | $m | [0.4](/filings/0001493152-23-040842.md) | [4.4](/filings/0001641172-25-001611.md) | [3.7](/filings/0001493152-24-019120.md) | [3.2](/filings/0001493152-24-031883.md) | [2.7](/filings/0001493152-24-045337.md) | [1.9](/filings/0001493152-26-016297.md) | [24.0](/filings/0001641172-25-010660.md) | [23.4](/filings/0001641172-25-023358.md) | [22.8](/filings/0001493152-25-022092.md) | [22.5](/filings/0001493152-26-037992.md) | [22.1](/filings/0001493152-26-023388.md) | [22.1](/filings/0001493152-26-037992.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(254) d](/filings/0001493152-24-045337.md) | [(1,006) d](/filings/0001641172-25-001611.md) | [(1,243)](/filings/0001641172-25-010660.md) | [(413) d](/filings/0001641172-25-023358.md) | [(425) d](/filings/0001493152-25-022092.md) | [(645) d](/filings/0001493152-26-016297.md) | [(1,454)](/filings/0001493152-26-023388.md) | [(494) d](/filings/0001493152-26-037992.md) | [(257) d](/filings/0001493152-25-022092.md) | [(208) d](/filings/0001493152-26-016297.md) | [(395)](/filings/0001493152-26-023388.md) | [(110) d](/filings/0001493152-26-037992.md) |
| Capital expenditure | $k | not reported | not reported | not reported | not reported | not reported | not reported | [0.6](/filings/0001493152-26-023388.md) | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [75.5](/filings/0001493152-23-040842.md) | [75.5](/filings/0001493152-24-019120.md) | [75.5](/filings/0001493152-24-031883.md) | [3.8](/filings/0001493152-24-045337.md) | [3.9](/filings/0001641172-25-010660.md) | [3.8](/filings/0001641172-25-023358.md) | [3.9](/filings/0001493152-25-022092.md) | [0.2](/filings/0001493152-26-023388.md) | [1.0](/filings/0001493152-26-037992.md) | [50.0](/filings/0001493152-25-022092.md) | [1.0](/filings/0001493152-26-023388.md) | [1.0](/filings/0001493152-26-037992.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 1,000,626 at 2026-08-10, from the cover of the [10-Q filed 2026-08-14](/filings/0001493152-26-037992.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:46 ET. No prices; not investment advice.